by Lee Jungyun
Published 20 Apr.2022 10:18(KST)
[Asia Economy Reporter Lee Jung-yoon] Hugel announced on the 20th that it has obtained German product approval for Botulax (export name Letybo) 50 units from the German Federal Institute for Drugs and Medical Devices.
The company stated, "We expect this to contribute to full-scale entry into the local market and expansion of overseas sales," adding, "We plan to establish sales strategies tailored to the characteristics of the local market with our European partner and carry out marketing activities."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.